Conjunctivitis secondary prevention

Jump to navigation Jump to search

Conjunctivitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Conjunctivitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Conjunctivitis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Conjunctivitis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Conjunctivitis secondary prevention

CDC on Conjunctivitis secondary prevention

Conjunctivitis secondary prevention in the news

Blogs on Conjunctivitis secondary prevention

Directions to Hospitals Treating Conjunctivitis

Risk calculators and risk factors for Conjunctivitis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

There is no established method for secondary prevention of conjunctivitis except among newborns. Secondary prevention strategies following allergic conjunctivitis include Educating patients about disease process and precipitating factors is very important.There is no established method for secondary prevention of allergic conjunctivitis. however, identify the allergen and avoid the offending [[antigen] is very important. In keratoconjunctivitis sicca (dry eye syndrome) and superior limbic keratoconjunctivitis, educating patients about disease process and precipitating factors may be help prevent the progression of disease and possible morbidity.

Secondary Prevention

Routine use of 0.5% erythromycin, or 1% tetracycline ophthalmic ointments or drops instilled into each eye after delivery effectively prevents gonococcal ophthalmia. However, none of these agents prevents chlamydial ophthalmia neonatorum; povidone iodine 2.5% drops may be effective against chlamydia and gonococci but is not available in the US.[1]

There is no established method for secondary prevention in other subtypes of conjunctivitis. however, it may be helpful to consider following secondary prevention strategies such as:

References

  1. Matejcek A, Goldman RD (2013). "Treatment and prevention of ophthalmia neonatorum". Can Fam Physician. 59 (11): 1187–90. PMC 3828094. PMID 24235191.

Template:WS Template:WH